ArticleInteractive journal of medical research2026

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study.

Jacqueline K Kueper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.